Difference between revisions of "Denintuzumab mafodotin (SGN-CD19A)"
Jump to navigation
Jump to search
(Created page with "=Mechanism of action= Antibody-drug conjugate =Preliminary studies= # '''Abstract:''' Andres Forero-Torres, Craig Moskowitz, Ranjana H. Advani, Bijal D. Shah, Ana Kostic, Tin...") |
m |
||
| Line 4: | Line 4: | ||
=Preliminary studies= | =Preliminary studies= | ||
# '''Abstract:''' Andres Forero-Torres, Craig Moskowitz, Ranjana H. Advani, Bijal D. Shah, Ana Kostic, Tina M. Albertson, Larissa Sandalic, Baiteng Zhao, Michelle A. Fanale. Interim analysis of a phase 1, open-label, dose-escalation study of SGN-CD19A in patients with relapsed or refractory B-lineage non-Hodgkin lymphoma (NHL). J Clin Oncol 32:5s, 2014 (suppl; abstr 8505) [http://meetinglibrary.asco.org/content/127120-144 link to original abstract] | # '''Abstract:''' Andres Forero-Torres, Craig Moskowitz, Ranjana H. Advani, Bijal D. Shah, Ana Kostic, Tina M. Albertson, Larissa Sandalic, Baiteng Zhao, Michelle A. Fanale. Interim analysis of a phase 1, open-label, dose-escalation study of SGN-CD19A in patients with relapsed or refractory B-lineage non-Hodgkin lymphoma (NHL). J Clin Oncol 32:5s, 2014 (suppl; abstr 8505) [http://meetinglibrary.asco.org/content/127120-144 link to original abstract] | ||
| + | |||
| + | [[Category:Drug index]] | ||
| + | [[Category:Chemotherapy]] | ||
| + | [[Category:Intravenous chemotherapy]] | ||
| + | |||
| + | [[Category:Antibody medications]] | ||
| + | [[Category:Antibody-drug conjugates]] | ||
| + | [[Category:Anti-CD19 antibodies]] | ||
[[Category:Investigational]] | [[Category:Investigational]] | ||
| − | |||
Revision as of 20:34, 26 November 2014
Mechanism of action
Antibody-drug conjugate
Preliminary studies
- Abstract: Andres Forero-Torres, Craig Moskowitz, Ranjana H. Advani, Bijal D. Shah, Ana Kostic, Tina M. Albertson, Larissa Sandalic, Baiteng Zhao, Michelle A. Fanale. Interim analysis of a phase 1, open-label, dose-escalation study of SGN-CD19A in patients with relapsed or refractory B-lineage non-Hodgkin lymphoma (NHL). J Clin Oncol 32:5s, 2014 (suppl; abstr 8505) link to original abstract